First-line medications for alcohol use disorders among public drug plan beneficiaries in Ontario.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Canadian family physician Medecin de famille canadien

• Publication date

  2017-05-01

• Fields of study

  Medicine

• Identifiers
  PMID 28500210PMCID PMC5429069
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Canadian Perspective on Addiction Treatment

  2014cited by this paper
• Failure of Physicians to Prescribe Pharmacotherapies for Addiction : Regulatory Restrictions and Physician Resistance

  2014cited by this paper
• Drinking behaviour and alcohol-related harm amongst older adults: analysis of existing UK datasets

  2014cited by this paper
• Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis.

  2014cited by this paper
• Pharmacotherapy for alcohol dependence: perceived treatment barriers and action strategies among Veterans Health Administration service providers.

  2013cited by this paper
• Reducing Appointment No-Shows: Going from Theory to Practice

  2013cited by this paper
• Epidemiology of alcohol and drug use in the elderly

  2013cited by this paper
• Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?

  2013cited by this paper
• Wait times for publicly funded addiction and problem gambling treatment agencies in Ontario, Canada

  2013cited by this paper
• Global alcohol exposure estimates by country, territory and region for 2005--a contribution to the Comparative Risk Assessment for the 2010 Global Burden of Disease Study.

  2013cited by this paper
• Risk of incident diabetes among patients treated with statins: population based study

  2013cited by this paper
• Alcohol and Drug Use Disorders among Patients with Myocardial Infarction: Associations with Disparities in Care and Mortality

  2013cited by this paper
• Use of naltrexone for alcohol use disorders in the Veterans' Health Administration: a national study.

  2013cited by this paper
• Alcohol use disorders in the elderly: a brief overview from epidemiology to treatment options.

  2012cited by this paper
• Postpartum maternal codeine therapy and the risk of adverse neonatal outcomes: A retrospective cohort study

  2012cited by this paper
• Acamprosate for alcohol dependence: a sex-specific meta-analysis based on individual patient data.

  2012cited by this paper
• Clinical recognition and recording of alcohol disorders by clinicians in primary and secondary care: meta-analysis

  2012cited by this paper
• Barriers to Use of Pharmacotherapy for Addiction Disorders and How to Overcome Them

  2011cited by this paper
• Days to treatment and early retention among patients in treatment for alcohol and drug disorders.

  2011cited by this paper
• Opioid dose and drug-related mortality in patients with nonmalignant pain.

  2011cited by this paper
• The efficacy of disulfiram for the treatment of alcohol use disorder.

  2011cited by this paper
• Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence.

  2011cited by this paper
• Acamprosate for alcohol dependence

  2010cited by this paper
• Elderly alcoholics in outpatient treatment.

  2010cited by this paper
• [Public attitudes towards alcohol dependence].

  2010cited by this paper
• Facilitating Factors and Barriers to the Use of Medications in Publicly Funded Addiction Treatment Organizations

  2010cited by this paper
• Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study.

  2010cited by this paper
• Opioid antagonists for alcohol dependence.

  2010cited by this paper
• Comparison of healthcare utilization among patients treated with alcoholism medications.

  2010cited by this paper
• Opioid antagonists for alcohol dependence.

  2010cited by this paper
• Canadian Agency for Drugs and Technologies in Health

  2009cited by this paper
• Family Physician attitudes about prescribing using a drug formulary

  2009cited by this paper
• Availability of addiction medications in private health plans.

  2008cited by this paper
• Naltrexone and cognitive behavioral therapy for the treatment of alcohol dependence: do sex differences exist?

  2008cited by this paper
• Timeliness and Efficiency

  2007cited by this paper
• Readiness to Change in Primary Care Patients Who Screened Positive for Alcohol Misuse

  2006cited by this paper
• Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation.

  2006cited by this paper
• Trends in the Adoption of Medications for Alcohol Dependence

  2006cited by this paper
• Alcoholism in the elderly: a study of elderly alcoholics compared with healthy elderly and young alcoholics.

  2006cited by this paper
• Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.

  2004cited by this paper
• Datapoints: Trends in naltrexone use among members of a large private health plan.

  2004cited by this paper
• Alcohol and illicit drug dependence.

  2004cited by this paper
• Use of naltrexone in the treatment of alcoholism nationally in the Department of Veterans Affairs.

  2003cited by this paper
• Alcohol Abuse: Prevalence and Detection in a General Hospital

  2002cited by this paper
• Why Physicians Are Unprepared to Treat Patients Who Have Alcohol‐ and Drug‐related Disorders

  2001cited by this paper
• Alcohol problems in old age: a review of recent epidemiological research

  2000cited by this paper
• Annals of Internal Medicine Original Research Chlorthalidone Versus Hydrochlorothiazide for the Treatment of Hypertension in Older Adults A Population-Based Cohort Study

  year unknowncited by this paper

• Circumstances surrounding alcohol toxicity deaths and prior pharmacotherapy for alcohol use disorder in Ontario, Canada

  2025cites this paper
• Alcohol Sales and Adverse Events during the Covid-19 Pandemic.

  2025cites this paper
• EFFICACY OF MEDICATIONS FOR THE TREATMENT OF ALCOHOL USE DISORDER (AUD): A SYSTEMATIC REVIEW AND META-ANALYSIS CONSIDERING BASELINE AUD SEVERITY.

  2024cites this paper
• Analysis of Ohio Advanced Practice Registered Nurses’ Rate of Prescribing Naltrexone for Patients With Alcohol Use Disorder Since Elimination of the X-Waiver

  2024cites this paper
• Trend in Prescription Medication Utilization for Opioid Use Disorder and Alcohol Use Disorder From 2015 to 2021: A Population-wide Study in a Canadian Province

  2024cites this paper
• Effectiveness of psychosocial interventions for alcohol use disorder: a systematic review and meta-analysis update

  2024cites this paper
• Guidelines for Reasonable and Appropriate Care in the Emergency Department (GRACE‐4): Alcohol use disorder and cannabinoid hyperemesis syndrome management in the emergency department

  2024cites this paper
• Sobering Perspectives on the Treatment of Alcohol Use Disorder.

  2024cites this paper
• Ligne directrice canadienne pour la prise en charge clinique de la consommation d’alcool à risque élevé et du trouble d’utilisation de l’alcool

  2024cites this paper
• Rethinking Substance Use as Social History: Charting a Way Forward

  2024cites this paper
• Outcomes in Clinical Subgroups of Patients With Alcohol-Related Hospitalizations

  2024cites this paper
• Prescribing patterns, substance use disorder diagnoses, and access to treatment prior to substance-related toxicity deaths in Ontario

  2024influential citation
• Using a cascade of care framework to identify gaps in access to medications for alcohol use disorder in British Columbia, Canada.

  2023cites this paper
• Understanding Ohio X-Waivered Advanced Practice Registered Nurses’ Rate of Naltrexone Prescription for Alcohol Use Disordered Patients

  2023cites this paper
• Changes in health service use due to alcohol during the COVID-19 pandemic among individuals with and individuals without pre-existing alcohol-related medical diagnoses

  2023cites this paper
• Commentary on Socias et al.: It is time to be serious about AUD treatment disparities.

  2023cites this paper
• SAEM GRACE: Anti‐craving medications for alcohol use disorder treatment in the emergency department: A systematic review of direct evidence

  2023influential citation
• Canadian guideline for the clinical management of high-risk drinking and alcohol use disorder

  2023cites this paper
• Clarifying rural-urban disparities in alcohol-related emergency department visits and hospitalizations in Ontario, Canada: A spatial analysis.

  2022cites this paper
• Pharmacotherapies for Adults With Alcohol Use Disorders: A Systematic Review and Network Meta-analysis

  2022cites this paper
• Impact of policy changes and drug shortages on acamprosate and naltrexone use in Ontario, Canada.

  2022cites this paper
• Hazardous drinking and alcohol use disorders

  2022cites this paper
• Trends in the Use of Naltrexone for Addiction Treatment among Alcohol Use Disorder Admissions in U.S. Substance Use Treatment Facilities

  2021cites this paper
• Modernizing Withdrawal Management Services

  2021cites this paper
• First-line Medications for the Outpatient Treatment of Alcohol Use Disorder: A Systematic Review of Perceived Barriers

  2021influential citation
• Prescription opioid characteristics at initiation for non-cancer pain and risk of treated opioid use disorder: A population-based study.

  2021cites this paper
• Facilitating rapid access to addiction treatment: a randomized controlled trial

  2021cites this paper
• Use of pharmacotherapy for alcohol use disorder in Manitoba, Canada: A whole-population cohort study

  2021cites this paper
• A rapid access to addiction medicine clinic facilitates treatment of substance use disorder and reduces substance use

  2020influential citation
• Receipt of pharmacotherapy for alcohol use disorder by justice-involved women in the Veterans Health Administration

  2019cites this paper
• Unhelpful Prescribing in Alcohol Use Disorder: Risk and Averting Risk.

  2019cites this paper
• Improving the quality of health care in Canada

  2018cites this paper